Nanomaterials are currently widely exploited for their potential in the development of novel cancer therapies, and so far, mainly nanoparticles (NPs) consisting of liposomes and polymers have made their way...

Impranil DLN is a class of plastics belonging to the polyurethane family with high application in textile industries. The aim of this study was to evaluate the potential of native strain to degrade impranil DLN. In this study, yeast strains were isolated from different areas and purified in minimal medium containing 1% impranil. Isolate NS-10 was selected as the superior strain capable of degrading impranil and identified through PCR and ITS gene. Esterase, urease and protease assays were carried out for the superior strain. Finally, the biodegradation of impranil was investigated. In total, 40 yeast strains were isolated and isolate NS-10 was selected as a superior strain based on impranil removal assay. NS-10 strain was identified as Sarocladium kiliense with 100% homology. Enzymatic assays showed that the S. kiliense could produce esterase, urease and protease. In addition, it could produce significant clear zones on impranil plates. Degradation rate for impranil was 100% for 10 g/l within 14 days. Finally, S. kiliense was taken to medium containing pure polyurethane film and the capacity of degradation was investigated by the scanning electron microscopy. Our results indicated that S.kiliense is capable of degrading impranil. These results could contribute to a better insight into the mechanism of plastic biodegradation.

Nanoparticle-mediated cancer immunotherapy holds great promise, but more efforts are needed to obtain nanoformulations that result in a full scale activation of innate and adaptive immune components that specifically target the tumors. We generated a series of copper-doped TiO2 nanoparticles in order to tune the kinetics and full extent of Cu2+ ion release from the remnant TiO2 nanocrystals. Fine-tuning nanoparticle properties resulted in a formulation of 33% Cu-doped TiO2 which enabled short-lived hyperactivation of dendritic cells and hereby promoted immunotherapy. The nanoparticles result in highly efficient activation of dendritic cells ex vivo, which upon transplantation in tumor bearing mice, exceeded the therapeutic outcomes obtained with classically stimulated dendritic cells. Efficacious but simple nanomaterials that can promote dendritic cancer cell vaccination strategies open up new avenues for improved immunotherapy and human health. Graphical Abstract